Thursday, 20 December 2012

Merck says cholesterol drug failed to show benefit

Drugmaker Merck & Co. says it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.Results ...

Source: http://health.yahoo.net/news/s/ap/merck-says-cholesterol-drug-failed-to-show-benefit

here found here more for more

No comments:

Post a Comment

Note: only a member of this blog may post a comment.